immunotherapy

Micrograph of malignant melanoma (copyright 2010, Nephron)
Micrograph of malignant melanoma (copyright 2010, Nephron)

What Determines Whether a Melanoma Patient Will Respond to Checkpoint Blockade Drugs?

In-Depth Insights |  Written by Emma Shtivelman, PhD

Of all cancer types, melanoma is the most investigated in terms of its potential to be treated through immune system-based approaches. More ...

Learn More
3D structure of a melanoma cell
3D structure of a melanoma cell derived by ion abrasion scanning electron microscopy. (Sriram Subramaniam, National Cancer Institute, 2012)

Immune Checkpoint Inhibitors in Melanoma: New Directions

In-Depth Insights |  Written by Emma Shtivelman, PhD

The drugs pembrolizumab (Keytruda) and nivolumab (Opdivo) were approved by the U.S. Food and Drug Administration (FDA) in 2014 and 2015, ...

Learn More